Determination of the Role of Oxygen in Suspected Acute Myocardial Infarction by Biomarkers (DETO2X-bio)
Acute Myocardial Infarction (AMI), Acute Coronary Syndrome (ACS), ST Elevation (STEMI) Myocardial Infarction
About this trial
This is an interventional treatment trial for Acute Myocardial Infarction (AMI) focused on measuring acute myocardial infarction (AMI), acute coronary syndrome (ACS), ST-segment elevation myocardial infarction (STEMI), Non ST-segment elevation myocardial infarction (NSTEMI), Ischemic Reperfusion injury (IR-injury), Biomarkers, Oxygen, Apoptosis, Fluorescence-activated cell sorting (FACS), Flow cytometry, Matrix metalloproteinase (MMP)
Eligibility Criteria
Inclusion Criteria:
- symptoms (chest pain, dyspnea) indicating acute myocardial ischemia within the last 6 hours
- ECG changes (ST-segment elevation ≥ 2 mm V1-V4, or ≥ 1 mm in other leads, ST-segment depression >1 mm in any lead, negative T-wave in leads V2-V6, pathological Q-wave in at least 2 adjacent leads), left bundle branch block
and/or elevated levels of cardiac troponin levels in the emergency department indicating acute myocardial ischemia
- oxygen saturation ≥90% (pulse oximeter)
- age ≥30
Exclusion Criteria:
- unwillingness to participate
- inability to comprehend given information
- continuous oxygen delivery at home prior to inclusion
- cardiac arrest prior to inclusion
Sites / Locations
- Linköping University Hospital
- Södersjukhuset
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Oxygen
No oxygen
For patients randomized to oxygen therapy: 6 L/min of oxygen delivered by oxymask® started immediately after inclusion of the ambulance service or in the emergency department given continuously for 6-12 hours (at least 6 hours) all patients receive standard acute coronary syndrome treatment including reperfusion strategies
For patients randomized to withholding oxygen treatment no oxygen is administered at any time as long as the oxygen saturation is ≥90% on pulse oximeter (repetitive checks are performed) all patients receive standard acute coronary syndrome treatment including reperfusion strategies observation duration 12 hours